Selda Samakoglu Email & Phone Number
Chief Medical Officer @ Aveta Biomics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Selda Samakoglu Location
- Bedford, MA, US
Selda Samakoglu Work
- 2025 -now Chief Medical Officer @
- 2021 -2025 Executive Director, Clinical Development, Oncology @
- 2020 -2021 Senior Director, Clinical Development, Oncology @
- 2018 -2020 Director, Early Clinical and Translational Development @
- 2017 -2018 Director, Clinical and Translational Medicine, Lead of Hematology-Oncology Franchises @
- 2015 -2017 Director, Lead of Translational Medicine-Oncology @
- 2014 -2015 Director, Early Clinical and Translational Medicine Expert, Oncology @
- 2012 -2014 Senior Clinical Biomarker Lead of Biology-Biomarkers @
- 2010 -2012 Principal Scientist, Head of pharmacodynamic biomarkers and mechanism of action group @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
- 2008 -2010 Senior Scientist III @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
- 2004 -2008 Assistant Professor @ Weill Cornel Medical College
- 2002 -2007 Principal Investigator @ Memorial Sloan Kettering Cancer Center,
- 2002 -2007 Principal Investigator @ Memorial Sloan Kettering Cancer Center,
- 1999 -2002 Post Doctoral Research Fellow @ Institute Pasteur, Paris
- 2000 -2001 Visiting Research Fellow @ GENETHON-Centre
Selda Samakoglu Education
- Erasmus University School of Medicine in Rotterdam, Holland / Akdeniz University in Antalya, Turkey
Ph.D (Molecular Biology and Medical Biology)
1993-1998 - Hacettepe University in Ankara, Turkey / Mt Sinai School of Medicine
MD (Medicine / Oncology)
Selda Samakoglu Skills
- Oncology
- Cell
- ELISA
- Molecular Biology
- In Vivo
- Biomarkers
- Cancer
- Lifesciences
- Assay Development
- Pharmacology
- PCR
- Clinical Development
- Drug Development
- Immunohistochemistry
- Genomics
- Animal Models
- Genetics
- GLP
- Clinical Trials
- Translational Research
- Antibodies
- Biotechnology
- Biomarker Discovery
- Cell Biology
- Clinical Research
- FACS
- Good Laboratory Practice (GLP)
- Immunology
- Life Sciences
- Monoclonal Antibodies
- RNAi
- Leadership
- Public Speaking
- Biology
- Strategy
- Medicine
- Program Management
- Management
- Science
- Services
- Hospitals
- Research
- Good Laboratory Practice Glp
- Cell Culture
- Good Laboratory Practice
Selda Samakoglu Summary
- Selda Samakoglu, based in Bedford, MA, US, is currently a Chief Medical Officer at Aveta Biomics Inc. Selda Samakoglu brings experience from previous roles at Iovance Biotherapeutics, Inc., Replimune, CSL Behring, Early Clinical Development Program, Inherited Forms of Anemias, Thr and Bristol-Myers Squibb. Selda Samakoglu holds a 1993 - 1998 Ph.D in Molecular Biology and Medical Biology @ Erasmus University School of Medicine in Rotterdam, Holland / Akdeniz University in Antalya, Turkey. With a robust skill set that includes Oncology, Cell, ELISA, Molecular Biology, In Vivo and more. Selda Samakoglu has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Selda Samakoglu?
Find contact details for 700 million professionals.
Others Named Selda Samakoglu
Selda Samakoglu
Chief Medical Officer
Bedford, MA, US
Top Aveta Biomics Employees
Selda Samakoglu
Chief Medical Officer
Bedford, MA, US
Thomas Rudolph
Member Board of Directors
Stuttgart, BW, DE
Murat Budak
Medical Director at Aveta
West Chester, PA, US
Jan Hagemeier
Special Advisor
Vero Beach, FL, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co